Stuart A Arbuckle

CIK 1557290 · EVP, COO · last filed 2026-05-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.38M

Companies

6

Total Filings

149

Lifetime Open-Market Net

-$139.91M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALNY Director 671 $282.85 $189.8K $0 2 2026-05-22
PRAX Director 1,166 $266.58 $310.8K $0 1 2026-02-10
VRTX EVP, COO 63,508 $444.93 $28.26M -$139.91M 122 2025-07-02
RYTM Director 7,000 $88.38 $618.7K $0 9 2025-06-26
ImmunoGen, Inc. (IMGN) Delisted Director 0 $31.23 $0 $0 11 2024-02-12
Dare Bioscience, Inc. (CERU) Delisted Director 13,104 $0 4 2017-01-05

Recent Filings · Page 6 of 15

149 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-06-17 ImmunoGen, Inc. (IMGN) Delisted Grant (A) $0 EDGAR
2021-06-11 RYTM Grant (A) $0 EDGAR
2021-05-19 VRTX Sell (S) −109 -$23.6K EDGAR
2021-02-26 VRTX Mixed −6,532 -$1.41M EDGAR
2021-02-19 VRTX Mixed −14,065 -$2.98M EDGAR
2021-02-16 VRTX Sell (S) −5,156 -$1.09M EDGAR
2021-02-12 VRTX Tax (F) −3,101 -$664.1K EDGAR
2021-02-05 VRTX Mixed +34,778 -$197.7K EDGAR
2020-11-18 VRTX Sell (S) −7 -$1.6K EDGAR
2020-11-05 VRTX Mixed -$194.7K EDGAR
Showing 5160 of 149
Page 6 of 15
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.